N/A
Manufactured by The Procter & Gamble Manufacturing Company
9 FDA adverse event reports analyzed
Last updated: 2026-04-15
ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by The Procter & Gamble Manufacturing Company. The most commonly reported adverse reactions for ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY include ANAPHYLACTIC REACTION, APPLICATION SITE ERYTHEMA, APPLICATION SITE PAIN, APPLICATION SITE PRURITUS, BREAST CANCER. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY.
Out of 4 classified reports for ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 9 FDA FAERS reports that mention ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include ANAPHYLACTIC REACTION, APPLICATION SITE ERYTHEMA, APPLICATION SITE PAIN, APPLICATION SITE PRURITUS, BREAST CANCER, RASH. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list The Procter & Gamble Manufacturing Company in connection with ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY. Always verify the specific product and NDC with your pharmacist.